Survey: Endocrinologists would prescribe Bydureon for 20% of patients
Decision Resources predicts drug to capture 2.6% of market share by 2020
Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.
Post a Comment
Footer Content
Retail Group
Events - Retail
Industry Guides, Research & Reports
International
footer
© 2012 Drug Store News. All Rights Reserved.